Works by Dong, Xuyuan

Results: 9

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review.

Published in:

Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920940932

By:

Wu, Yinying;
Fan, Yangwei;
Dong, Danfeng;
Dong, Xuyuan;
Hu, Yuan;
Shi, Yu;
Jing, Jiayu;
Li, Enxiao

Publication type:

Article

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.

Published in:

Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 1, p. 760, doi. 10.1111/jcmm.14785

By:

Shi, Yu;
Fan, Yangwei;
Hu, Yuan;
Jing, Jiayu;
Wang, Chuying;
Wu, Yinying;
Geng, Qianqian;
Dong, Xuyuan;
Li, Enxiao;
Dong, Danfeng

Publication type:

Article

The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia.

Published in:

Annals of Clinical & Laboratory Science, 2019, v. 49, n. 4, p. 448

By:

Chuying Wang;
Jiao Yu;
Yangwei Fan;
Ke Ma;
Jing Ning;
Yuan Hu;
Wenxia Niu;
Xuyuan Dong;
Yinying Wu;
Enxiao Li;
Danfeng Dong

Publication type:

Article

Comprehensive analysis of immunogenic cell death-related genes in liver ischemia-reperfusion injury.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1545185

By:

Lu, Kai;
Li, Hanqi;
Sun, Liankang;
Dong, Xuyuan;
Fan, Yangwei;
Dong, Danfeng;
Wu, Yinying;
Shi, Yu

Publication type:

Article

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 6075, doi. 10.2147/OTT.S115054

By:

Yangwei Fan;
Ke Ma;
Chuying Wang;
Jing Ning;
Yuan Hu;
Danfeng Dong;
Xuyuan Dong;
Qianqian Geng;
Enxiao Li;
Yinying Wu

Publication type:

Article

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-020-01812-7

By:

Shi, Yu;
Sun, Liankang;
Zhang, Rui;
Hu, Yuan;
Wu, Yinying;
Dong, Xuyuan;
Dong, Danfeng;
Chen, Chen;
Geng, Zhimin;
Li, Enxiao;
Fan, Yangwei

Publication type:

Article

A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma.

Published in:

Clinical Epigenetics, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13148-025-01894-0

By:

Wu, Yinying;
Fan, Yangwei;
Dong, Xuyuan;
Dong, Danfeng;
Shi, Yu;
Wang, Meichen;
Wang, Jia;
Yang, Yuqian;
Yang, Nan;
Ou, Fengyun;
Li, Enxiao

Publication type:

Article

Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.

Published in:

Oncology Reports, 2016, v. 35, n. 6, p. 3505, doi. 10.3892/or.2016.4711

By:

KE MA;
CHUYING WANG;
QIANQIAN GENG;
YANGWEI FAN;
JING NING;
HAIXIA YANG;
XUYUAN DONG;
DANFENG DONG;
YUYAN GUO;
XIN WEI;
ENXIAO LI;
YINYING WU

Publication type:

Article

Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation.

Published in:

Environmental Toxicology, 2022, v. 37, n. 3, p. 527, doi. 10.1002/tox.23418

By:

Hu, Yuan;
Zhang, Pengchuang;
Shi, Yu;
Dong, Xuyuan;
Wu, Yinying;
Dong, Danfeng;
Li, Enxiao;
Fan, Yangwei

Publication type:

Article